Guarino M, Giordano F, Pallotti F, Polizzotti G, Tricomi P, Cristofori E
Department of Pathology, Hospital of Vimercate, Italy.
Tumori. 1998 May-Jun;84(3):391-7. doi: 10.1177/030089169808400316.
Various histogenetic mechanisms have been postulated to explain the biphasic carcinomatous-sarcomatous appearance of malignant mixed mullerian tumors (MMMTs), but the nature of these uncommon neoplasms is still unclear. Some evidence would suggest that MMMT displays similarities with sarcomatoid carcinoma, a tumor arising in extragenital sites that also features a mixed appearance. To gain further insight into the histogenesis of this tumor, we have studied by immunohistochemistry a case of uterine MMMT showing an extensive rhabdomyosarcomatous component.
A panel of antibodies including reactivity for p53, cytokeratin, vimentin, desmin, muscle actin, epithelial membrane antigen (EMA), myoglobin, type IV collagen, laminin, and tenascin was applied to paraffin tumor sections by means of the avidin-biotin complex technique.
p53 immunoreactivity was observed in approximately the same number of cells in carcinomatous and sarcomatous tissue. The former stained for vimentin, cytokeratin and EMA, while the latter, in addition to expressing vimentin, desmin, muscle actin and myoglobin, also exhibited immunoreactivity for epithelial markers such as cytokeratin and EMA. At the borders between carcinoma and sarcoma the basement membrane pattern, as seen by staining for type IV collagen and laminin, showed interruptions in correspondence with areas of transition between the two tissues. Antibody to tenascin strongly labeled the sarcomatous tissue immediately around carcinomatous elements.
A similar immunoreactivity for p53 in both carcinomatous and sarcomatous components, expression of epithelial markers in the sarcomatous cells, and disruption of the basement membrane profile in areas of transition between carcinomatous and sarcomatous tissue, would all suggest, as has been postulated for extragenital sarcomatoid carcinomas, an origin from a common epithelial clone and an epithelial-to-mesenchymal transformation-based mechanism of development for this MMMT. In addition, these findings provide further analogies between these categories of tumors, supporting a unifying nosological concept for MMMTs and sarcomatoid carcinomas of non-genital tract origin.
人们提出了多种组织发生机制来解释恶性苗勒管混合瘤(MMMTs)的癌肉瘤双相外观,但这些罕见肿瘤的本质仍不清楚。一些证据表明,MMMT与肉瘤样癌有相似之处,肉瘤样癌是一种发生于生殖器外部位的肿瘤,也具有混合外观。为了进一步深入了解这种肿瘤的组织发生,我们通过免疫组织化学研究了一例具有广泛横纹肌肉瘤成分的子宫MMMT。
通过抗生物素蛋白-生物素复合物技术,将一组包括对p53、细胞角蛋白、波形蛋白、结蛋白、肌动蛋白、上皮膜抗原(EMA)、肌红蛋白、IV型胶原、层粘连蛋白和腱生蛋白有反应性的抗体应用于石蜡包埋的肿瘤切片。
在癌组织和肉瘤组织中,观察到p53免疫反应性的细胞数量大致相同。前者对波形蛋白、细胞角蛋白和EMA染色,而后者除了表达波形蛋白、结蛋白、肌动蛋白和肌红蛋白外,对细胞角蛋白和EMA等上皮标志物也表现出免疫反应性。在癌与肉瘤的边界处,通过IV型胶原和层粘连蛋白染色所见的基底膜模式,在两种组织的过渡区域对应处显示中断。腱生蛋白抗体强烈标记癌组织周围紧邻的肉瘤组织。
癌组织和肉瘤组织中p53的免疫反应性相似、肉瘤细胞中上皮标志物的表达以及癌组织和肉瘤组织过渡区域基底膜轮廓的破坏,都表明,如同生殖器外肉瘤样癌的推测,该MMMT起源于一个共同的上皮克隆,并基于上皮-间充质转化的发育机制。此外,这些发现为这些类型的肿瘤提供了进一步的相似性,支持了MMMTs和非生殖道起源的肉瘤样癌的统一疾病分类概念。